Literature DB >> 11012135

Congenital chylothorax.

K Al-Tawil1, G Ahmed, M Al-Hathal, Y Al-Jarallah, N Campbell.   

Abstract

The objective of this paper is a retrospective study of all infants treated for congenital chylothorax at the Royal Children's Hospital (RCH), Melbourne, Australia and King Fahad National Guard Hospital (KFNGH), Riyadh, Kingdom of Saudi Arabia. The charts of all infants with congenital chylothorax admitted to RCH over a period of 13 years, June 1982-August 1994, and admissions to KFNGH over a 7-year period, June 1992-August 1998 inclusive, were reviewed including management outcome and complications. There were 19 infants, 13 from RCH and 6 from KFNGH; 11 females and 8 males. Three infants were managed antenatally. Fifteen infants presented immediately after birth. Seven were born with hydrops fetalis, 6 infants had syndromes and 10 infants were born prematurely. Regular infant feeding formula and/or breast milk were used successfully in 12 infants, while in 7 infants medium chain triglycerides (MCT) rich formula was used. Sixteen infants were mechanically ventilated with 75% of them ventilated for < or = 28 days. Fifteen infants received total parenteral nutrition (TPN), and in 80% for < or = 32 days. Hydropic infants had longer duration of mechanical ventilation and hospital stay with mean (range) of 33.9 (3-120) and 115 (23-225) days, respectively, compared with 18 (1-62) and 34.3 (14-88) days for nonhydropic infants. Five infants underwent surgery with failure in four. Sepsis and bronchopulmonary dysplasia were the main complications. The survival rate was 100% regardless of the mode of therapy. The prognosis of Isolated congenital chylothorax in term, and preterm infants is good even in the presence of hydrops. Breast milk and/or regular infant feeding formula should be used initially before proceeding to MCT-rich formula, which may be necessary in some cases. Surgery should be considered if conservative management of congenital chylothorax fails after 4-5 weeks.

Entities:  

Mesh:

Year:  2000        PMID: 11012135     DOI: 10.1055/s-2000-9281

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  14 in total

1.  Idiopathic congenital chylothorax treated with octreotide.

Authors:  Paulo Rego Sousa; Henrique Leitão; Maria Carmo Camacho; José Luis Nunes
Journal:  BMJ Case Rep       Date:  2010-05-19

2.  Thoracoscopic pleural clipping for the management of congenital chylothorax.

Authors:  Margaret E Clark; Russell K Woo; Sidney M Johnson
Journal:  Pediatr Surg Int       Date:  2015-08-15       Impact factor: 1.827

Review 3.  [Therapy management of chylothorax].

Authors:  S Bölükbas; N Kudelin; T Dönges; J Schirren
Journal:  Chirurg       Date:  2010-03       Impact factor: 0.955

4.  Lactobezoar formation in two premature infants receiving medium-chain triglyceride formula.

Authors:  M Prahl; D Smetana; N Porta
Journal:  J Perinatol       Date:  2014-08       Impact factor: 2.521

5.  Congenital chylothorax treated with octreotide.

Authors:  Yasin Sahin; Derya Aydin
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

6.  Pleural effusion in a neonate.

Authors:  Sandeep Krishnanand Shetty; Mark Butler
Journal:  BMJ Case Rep       Date:  2011-08-11

7.  Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion.

Authors:  Jeong Eun Kim; Chul Lee; Kook In Park; Min Soo Park; Ran Namgung; In Kyu Park
Journal:  Korean J Pediatr       Date:  2012-05-21

8.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 9.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

10.  Bilateral Chylothorax Complicating a Case of Chronic Lymphocytic Leukemia: A Case Report.

Authors:  Munish Sharma; Divakar Sharma
Journal:  Clin Pract       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.